<DOC>
	<DOC>NCT01139190</DOC>
	<brief_summary>The purpose of this study is to determine the subchronic gastrointestinal (GI) safety of PL3100 versus Naproxen in normal healthy volunteers.</brief_summary>
	<brief_title>Clinical Trial Evaluating Gastrointestinal Damage Following Administration PL3100 or Naproxen in At-Risk Adults</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Naproxen</mesh_term>
	<criteria>Inclusion Criteria (Selected) Male and female healthy adult subjects Exclusion Criteria (Selected) Subject has protocol specified significant medical history. Subject is currently participating, or has participated within 30 days prior to study entry, in an investigational drug study. Subject has hypersensitivity or contraindications to naproxen, ibuprofen, or other NSAID.</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>NSAID-induced gastroduodenal ulcerations or erosion</keyword>
</DOC>